Published in Medicine and Law Weekly, March 16th, 2007
This trend article about Rene Descartes University, France, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New investigation results, "Retention rates of tumor necrosis factor blockers in daily practice in 770 rheumatic patients," are detailed in a study published in Journal of Rheumatology. "Tumor necrosis factor (TNF) blockers are efficacious in clinical trials in rheumatic diseases. However, their efficacy in daily practice, depending on the specific diagnosis or the use of concomitant therapy, remains to be confirmed," scientists...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.